Aurora announces Q4 and full financial year 2017 results

Aurora Cannabis Inc.(TSX: ACB) (OTCQX: ACBFF) today announced its financial and operational results for the fourth quarter and full financial year ended June 30, 2017.

Q4 2017 Financial and Operational Highlights

  • Recorded $5.9 million in revenues, reflecting growth in patient numbers and an increase in the average price per gram of product sold, which now includes high margin cannabis oils.
  • Continued to progress on schedule and on budget with the construction of the Company's Aurora Sky facility.
  • Completed the acquisition of Pedanios GmbH, Germany's largest distributor of cannabis. This acquisition provides access to the single largest federally-legal medical cannabis market in the world, as well as a gateway to the rapidly-developing EU market. Increasing momentum in the EU towards the adoption of medical cannabis legislation has the potential to create a market of several hundred million people.
  • Completed the acquisition of Peloton Pharmaceuticals, a 40,000 square foot facility, which Aurora currently is completing, with
  • ...
e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: